Patrick J. McEnany - 13 Sep 2022 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
President and CEO, Director
Signature
/s/ Patrick J. McEnany
Issuer symbol
CPRX
Transactions as of
13 Sep 2022
Net transactions value
-$15,832,731
Form type
4
Filing time
15 Sep 2022, 17:01:35 UTC
Previous filing
19 Aug 2022
Next filing
22 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPRX Common stock, par value $0.001 per share Sale $1,238,047 -80,765 -1.6% $15.33 4,849,452 13 Sep 2022 Direct F1, F2
transaction CPRX Common stock, par value $0.001 per share Sale $14,594,684 -946,846 -20% $15.41 3,902,606 14 Sep 2022 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold for personal reasons. Shares were not sold as a result of any disagreement with the Company and Mr. McEnany remains a director and an officer of the Company.
F2 Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $15.30 to $15.385 per share.
F3 Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $15.25 to $15.71 per share.